Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
Cerva C, Colagrossi L, Maffongelli G, Salpini R, Di Carlo D, Malagnino V, Battisti A, Ricciardi A, Pollicita M, Bianchi A, Picardi A, Cudillo L, Cerretti R, De Angelis G, Cantonetti M, Andreoni M, Perno CF, Arcese W, Svicher V, Sarmati L.
Cerva C, et al. Among authors: maffongelli g.
Clin Microbiol Infect. 2016 Nov;22(11):946.e1-946.e8. doi: 10.1016/j.cmi.2016.07.021. Epub 2016 Jul 27.
Clin Microbiol Infect. 2016.
PMID: 27475741
Free article.